SPI
GILD icon

Santori & Peters Inc’s Gilead Sciences GILD Stock Holding History

Santori & Peters Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,568
Closed -$540K – 66
2020
Q4 		$540K Buy
+8,568
New +$517K 0.3% 40
2020
Q2 		– Sell
-6,429
Closed -$480K – 63
2020
Q1 		$480K Buy
+6,429
New +$444K 0.42% 36
2018
Q1 		– Sell
-335
Closed -$26K – 241
2017
Q4 		$26K Buy
+335
New +$25.4K 0.02% 159

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Santori & Peters Inc's GILD Position: Q1 2021 in Review

Santori & Peters Inc sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 8,568 shares — an estimated $540K sold.

Santori & Peters Inc first reported a position in GILD in Q4 2017 and held it in 3 quarters. The position peaked at $540K in Q4 2020. 1,568 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

  • Santori & Peters Inc reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
  • Santori & Peters Inc sold 8,568 Gilead Sciences shares in Q1 2021, an estimated $540K.
  • Santori & Peters Inc first reported a position in Gilead Sciences in Q4 2017 and held it in 3 quarters.
  • Santori & Peters Inc's Gilead Sciences position peaked at $540K in Q4 2020.
  • 1,568 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on Santori & Peters Inc's 13F filing for Q1 2021, filed 28 Apr 2021.